Cargando…

Handbook of animal models in Alzheimer's disease /

Animals have been used to model diseases or test new treatments since around 300 BC, and undoubtedly our ability to model disease in animals - including transgenic animals - has provided major breakthroughs in all fields of biomedical research. Due to their complexity and plurality of pathology and...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Casadesus, Gemma (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Amsterdam : IOS Press, [2011]
Colección:Advances in Alzheimer's disease (Series) ; v. 1.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000Mi 4500
001 EBSCO_ocn756484748
003 OCoLC
005 20231017213018.0
006 m o d
007 cr |n|---|||||
008 111010s2011 ne a obf 001 0 eng d
010 |z  2011928925 
040 |a EBLCP  |b eng  |e rda  |e pn  |c EBLCP  |d IOSPR  |d N$T  |d UKMGB  |d YDXCP  |d CUS  |d E7B  |d OCLCQ  |d OCLCF  |d OCLCQ  |d OCLCO  |d DEBSZ  |d IDEBK  |d OCL  |d OCLCQ  |d AGLDB  |d MERUC  |d K6U  |d ICG  |d LOA  |d STF  |d USU  |d OCLCO  |d JBG  |d AUW  |d OCLCO  |d PIFAG  |d FVL  |d ZCU  |d OCLCQ  |d U3W  |d WRM  |d OCLCQ  |d VTS  |d VT2  |d TOF  |d REC  |d AU@  |d OCLCQ  |d WYU  |d OCLCO  |d OCLCA  |d U3G  |d DKC  |d OCLCO  |d OCLCQ  |d OCLCO  |d M8D  |d OSU  |d OCLCQ  |d OCLCA  |d UKCRE  |d VLY  |d AJS  |d MHW  |d FWA  |d OCLCO  |d OCL  |d OCLCQ 
016 7 |a 015888518  |2 Uk 
019 |a 778615262  |a 816866092  |a 982068123  |a 992022438  |a 1037679686  |a 1038676912  |a 1055340472  |a 1066649268  |a 1081256698  |a 1087364887  |a 1153548930  |a 1162005435  |a 1228600261  |a 1241862284  |a 1264871889  |a 1290042067  |a 1297274284  |a 1297358112  |a 1300598213 
020 |a 9781607507338  |q (electronic bk.) 
020 |a 1607507331  |q (electronic bk.) 
020 |a 9781283289689 
020 |a 1283289687 
020 |a 9781607507321  |q (print) 
020 |a 1607507323  |q (print) 
020 |a 661328968X 
020 |a 9786613289681 
029 1 |a AU@  |b 000051449529 
029 1 |a DEBBG  |b BV043039934 
029 1 |a DEBSZ  |b 421525568 
029 1 |a DEBSZ  |b 43104807X 
029 1 |a NZ1  |b 14693797 
035 |a (OCoLC)756484748  |z (OCoLC)778615262  |z (OCoLC)816866092  |z (OCoLC)982068123  |z (OCoLC)992022438  |z (OCoLC)1037679686  |z (OCoLC)1038676912  |z (OCoLC)1055340472  |z (OCoLC)1066649268  |z (OCoLC)1081256698  |z (OCoLC)1087364887  |z (OCoLC)1153548930  |z (OCoLC)1162005435  |z (OCoLC)1228600261  |z (OCoLC)1241862284  |z (OCoLC)1264871889  |z (OCoLC)1290042067  |z (OCoLC)1297274284  |z (OCoLC)1297358112  |z (OCoLC)1300598213 
050 4 |a RC523  |b .H36 2011eb 
050 4 |a Z6665.7 .A45 
060 4 |a WT 155 
072 7 |a COM  |x MED057000  |2 bisacsh 
072 7 |a HEA  |x 039140  |2 bisacsh 
072 7 |a MED  |x 056000  |2 bisacsh 
072 7 |a MJC  |2 bicssc 
082 0 4 |a 616.831 
049 |a UAMI 
245 0 0 |a Handbook of animal models in Alzheimer's disease /  |c edited by Gemma Casadesus. 
264 1 |a Amsterdam :  |b IOS Press,  |c [2011] 
264 4 |c ©2011 
300 |a 1 online resource (x, 340 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Advances in Alzheimer's disease,  |x 2210-5727 ;  |v v. 1 
504 |a Includes bibliographical references and index. 
520 |a Animals have been used to model diseases or test new treatments since around 300 BC, and undoubtedly our ability to model disease in animals - including transgenic animals - has provided major breakthroughs in all fields of biomedical research. Due to their complexity and plurality of pathology and symptomatology, the study of neurodegenerative diseases relies heavily on animal models. These models have been developed in many species in the attempt to undercover the complex nature of the disease mechanisms involved. The ultimate goal is to test promising therapies and to manage, prevent or cure neurodegenerative disease. But because most animal models in this area do not reproduce the full phenotypical disease spectrum and the etiology and clinical presentation of neurodegenerative diseases differ from one patient to the next, the testing of these diseases in animal models often translates poorly to indices of efficacy when applied to the clinical population. Written by experts in the field with these advances and challenges in mind, this handbook provides an updated overview of the animal models being developed and used to study complex disease dynamics. The first part of the book presents an overview of animal models of various species and includes a review of new invertebrate animal models to study neurodegeneration. The second section presents the use of animal models to pinpoint disease mechanisms, and the last part of the handbook examines the various therapeutic interventions being used in models of neurodegenerative disease. 
505 0 |a Title; Preface; Contents; Section 1Overview of Animal Models of Alzheimer's Disease; Estimation of Working Memory in Macaques for Studying Drugs for the Treatment of Cognitive Disorders; The Canine Model of Human Aging and Disease; Unveiling "The Switch" from Aging to Alzheimer's Disease with the Senescence-Accelerated Mouse Model (SAMP8); Alzheimer's Disease Selective Vulnerability and Modelling in Transgenic Mice; The Cholesterol-Fed Rabbit as a Model of AD: The Old, the New and the Pilot; A Rabbit Model of Alzheimer's Disease: Valid at Neuropathological, Cognitive, and Therapeutic Levels. 
505 8 |a Transgenic Drosophila Models of Alzheimer's Amyloid-? 42 ToxicitySection 2 Using Animal Models to Understand Mechanisms of Disease; Estrogen, Progesterone and Hippocampal Plasticity in Rodent Models; Apparent Behavioral Benefits of Tau Overexpression in P301L Tau Transgenic Mice; Activation of Cell Cycle Proteins in Transgenic Mice in Response to Neuronal Loss But Not Aß and Tau Pathology; Electron Microscopic 3D Reconstruction Analysis of Amyloid Deposits in 3xTg-AD Mice and Aged Canines; The Cholesterol-Fed Rabbit as a Model System for Cholesterol-Alzheimer's Disease Studies. 
505 8 |a Hepatic Ceramide May Mediate Brain Insulin Resistance and Neurodegeneration in Type 2 Diabetes and Non-alcoholic SteatohepatitisAnimal Model of Insulin-Resistant BrainS tate: Intracerebroventricular Streptozotocin Injection Deteriorates Alzheimer-Like Changes in Tg2576 APP-Overexpressing Mice; Hippocampal Alterations in Rats Submitted to Streptozotocin-Induced Dementia Model: Neuroprotection with Aminoguanidine; Section 3 Alzheimer's Disease Therapies Using Animal Models. 
505 8 |a Developing Immunotherapies for Alzheimer's Disease Using a Cholesterol-Fed Rabbit Model in the Context of Th Cell DifferentiationAnti-Amyloid-ß Immunotherapy in Alzheimer's Disease: Relevance of Transgenic Mouse Studies to Clinical Trials; Heterogeneity in Red Wine Polyphenolic Contents Differentially Influences Alzheimer's Disease-Type Neuropathology and Cognitive Deterioration; Delivery of NGF to the Brain: Intranasal Versus Ocular Administration in Anti-NGF Transgenic Mice; Cholinomimetic Actions of Memantine on Learning and Hippocampal Plasticity. 
505 8 |a Cognitive Performances of Cholinergically Depleted Rats Following Chronic Donepezil AdministrationSubject Index; Author Index. 
588 0 |a Print version record. 
546 |a English. 
590 |a eBooks on EBSCOhost  |b EBSCO eBook Subscription Academic Collection - Worldwide 
650 0 |a Alzheimer's disease  |x Animal models  |v Handbooks, manuals, etc. 
650 0 |a Diseases  |x Animal models. 
650 1 2 |a Alzheimer Disease  |x physiopathology 
650 1 2 |a Alzheimer Disease  |x drug therapy 
650 2 2 |a Disease Models, Animal 
650 6 |a Maladie d'Alzheimer  |x Modèles animaux  |v Guides, manuels, etc. 
650 6 |a Maladies  |x Modèles animaux. 
650 7 |a HEALTH & FITNESS  |x Diseases  |x Alzheimer's & Dementia.  |2 bisacsh 
650 7 |a MEDICAL  |x Neurology.  |2 bisacsh 
650 7 |a Diseases  |x Animal models.  |2 fast  |0 (OCoLC)fst00895160 
650 7 |a Alzheimer's disease  |x Animal models.  |2 fast  |0 (OCoLC)fst00806534 
655 7 |a Handbooks and manuals.  |2 fast  |0 (OCoLC)fst01423877 
700 1 |a Casadesus, Gemma,  |e editor 
776 0 8 |i Print version:  |a Casadesus, G.  |t Handbook of Animal Models in Alzheimer's Disease.  |d Amsterdam : IOS Press, ©2011  |z 9781607507321 
830 0 |a Advances in Alzheimer's disease (Series) ;  |v v. 1.  |x 2210-5727 
856 4 0 |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=395238  |z Texto completo 
938 |a EBL - Ebook Library  |b EBLB  |n EBL784614 
938 |a ebrary  |b EBRY  |n ebr10506334 
938 |a ProQuest MyiLibrary Digital eBook Collection  |b IDEB  |n 328968 
938 |a YBP Library Services  |b YANK  |n 6935651 
994 |a 92  |b IZTAP